Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 40.50
Change Today 0.00 / 0.00%
Volume 0.0
MDGS On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
As of 10:24 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

medigus ltd (MDGS) Snapshot

Open
$41.00
Previous Close
$41.40
Day High
$43.40
Day Low
$40.40
52 Week High
04/14/15 - $58.90
52 Week Low
12/30/14 - $25.00
Market Cap
101.2M
Average Volume 10 Days
1.1M
EPS TTM
$-0.11
Shares Outstanding
249.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIGUS LTD (MDGS)

Related News

No related news articles were found.

medigus ltd (MDGS) Related Businessweek News

No Related Businessweek News Found

medigus ltd (MDGS) Details

Medigus Ltd., a medical device company, designs, develops, and sells endoscopic procedures and devices. The company offers Medigus Ultrasonic Surgical Endostapler system, an endoscope device comprising a surgical stapler, miniature camera, and an ultrasound sensor for incisionless treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 2000 and is headquartered in Omer, Israel.

Founded in 2000

medigus ltd (MDGS) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 1.9M
Founder and Global Chief Operating Officer
Total Annual Compensation: 1.1M
Chief Financial Officer
Total Annual Compensation: 630.0K
Executive Vice President
Total Annual Compensation: 523.0K
Chief Technology Officer
Total Annual Compensation: 635.0K
Compensation as of Fiscal Year 2014.

medigus ltd (MDGS) Key Developments

MediGus Ltd. Expands Camera Portfolio with New Micro ScoutCam 3.45

Medigus Ltd. announced the addition of micro ScoutCam 3.45 to its micro ScoutCam portfolio of products. micro ScoutCam 3.45 is a CMOS video camera that adapts Medigus’ proprietary technology to offer a cost-effective option to manufacturers of inspectional devices looking for quality images from a micro camera to visually access small or narrow spaces in the human body or in industrial settings but have been limited due to cost. micro ScoutCam 3.45 boasts a high-end objective and a CMOS sensor that is specifically designed for miniature dimensions. The camera head is already equipped with optics within a small diameter, making it particularly well-suited for incorporation into flexible or rigid endoscopic devices. Medigus developed the micro ScoutCam portfolio, which consists of a variety of micro CMOS and CCD video cameras, and includes micro ScoutCam 1.2. micro ScoutCam technology features optic and illumination solutions, micro sensors and high-end DSP video processors that can be tailored for both medical and industrial applications.

MediGus Ltd. Wins Additional Supply Order for Miniature Video Cameras in Support of NASA's Robotic Refueling Mission

MediGus Ltd. announced that the National Aeronautics and Space Administration (NASA) has awarded them with an additional supply order of Medigus' micro ScoutCam technology, consisting of specially designed miniature video cameras and advance video processing equipment, for use on NASA's Robotic Refueling Mission (RRM). Medigus will develop specially designed cameras, with a CMOS sensor, based on NASA's specifications. Medigus will supply NASA with the specially designed cameras for implementation on the next generation of the VIPIR.

MediGus Ltd. Announces Executive Changes

On June 1, 2015, MediGus Ltd. announced that Mr. Thomas A. Dempsey was terminated from his position and ceased serving as VP U.S. effective June 1, 2015. Mr. Jeremy S. Starkweather was appointed VP of US Sales & Marketing effective as of June 1, 2015. Mr. Starkweather has more than 15 years of medical device sales & marketing experience. Prior to joining Medigus, Jeremy was the Vice-President of Sales & Business Development at Xlumena. He led the US launch and commercialization efforts for the AXIOS Stent. He held multiple positions in sales, marketing, & market development.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGS:IT 40.50 0.00

MDGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGS.
View Industry Companies
 

Industry Analysis

MDGS

Industry Average

Valuation MDGS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIGUS LTD, please visit www.medigus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.